Could a simple arm cuff replace bloodletting for high altitude disease?
NCT ID NCT07562464
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a device that temporarily stops blood flow to the arms in short cycles, aiming to help people with high altitude polycythemia — a condition where the body makes too many red blood cells at high altitudes. The trial will involve 222 adults living above 2,500 meters for over 6 months. Participants will either receive standard medication or add the device treatment twice daily for 90 days to see if it lowers hemoglobin and hematocrit levels.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- remote ischemic conditioning device
- What this could lead to
- If it works, this could offer a non-drug way to reduce the need for blood removal in people with high altitude polycythemia.
- What could go wrong
- This is an early-stage trial with only 222 participants, so results may not apply to everyone. The device may not work better than standard care, and some people may find the procedure uncomfortable.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH-ALTITUDE POLYCYTHEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.